In January, follow-up results from the first six months of the British choroideremia gene therapy trial were published. At the Association for Vision Research and Ophthalmology meeting today, the team led by Dr. Robert…Read More
The first human trial of a gene therapy for choroideremia has announced preliminary results on six people: two of these patients have experienced significant improvements in vision. The findings were published in…Read More
A $5 million grant from Alberta’s provincial health funder is establishing a Canadian Centre of Excellence for ocular gene therapy research. Drs. Ian MacDonald and Tania Bubela at the University of Alberta…Read More
Dr. Ian MacDonald and his team at the University of Alberta are internationally recognized experts in the study of choroideremia, a rare blinding disease that typically affects young men beginning in adolescence….Read More
Join the Fight!
Learn how your support is helping to bring a future without blindness into focus! Be the first to learn about the latest breakthroughs in vision research and events in your community by subscribing to our e-newsletter that lands in inboxes the beginning of each month.